Uploaded July 2023 | Updated November 2026, 1 day ago
At Ending Age-Related Diseases 2022, Hanadie Yousef of Juvena Therapeutics led a discussion panel with Ashley Zehnder of Fauna Bio, Glenn Markov of Rejuvenation Technologies, and Maddalena Adorno of Dorian Therapeutics. The purpose of this panel was to discuss a full developmental pipeline with which to develop prospective drugs that directly target the diseases and hallmarks of aging.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#longevity #pharma #development
At Ending Age-Related Diseases 2022, Hanadie Yousef of Juvena Therapeutics led a discussion panel with Ashley Zehnder of Fauna Bio, Glenn Markov of Rejuvenation Technologies, and Maddalena Adorno of Dorian Therapeutics. The purpose of this panel was to discuss a full developmental pipeline with which to develop prospective drugs that directly target the diseases and hallmarks of aging.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#longevity #pharma #development










